Tag: Q4 FY25

Mid-cap Pharma Stock Akums Drugs Rebounds 35% from Apri...

Akums Drugs, a mid-cap pharma stock, has surged 35% from April 2025 lows. Explor...

Eraaya Lifespaces Edges Higher After Q4 FY25 Results: S...

raaya Lifespaces reports significant revenue growth in Q4 FY25, driven by strate...